{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T14:14:30Z","timestamp":1783260870162,"version":"3.54.6"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,5]]},"DOI":"10.7759\/cureus.112092","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T13:18:07Z","timestamp":1783257487000},"source":"Crossref","is-referenced-by-count":0,"title":["Super-refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome Triggered by Influenza A: A Pediatric Case Report"],"prefix":"10.7759","author":[{"given":"Malik","family":"Ocakdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17397","article-title":"International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. febrile infection-related epilepsy syndrome (FIRES): statements and supporting evidence","volume":"63","author":"Wickstrom R","year":"2022","unstructured":"Wickstrom R, Taraschenko O, Dilena R, et al.. International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. febrile infection-related epilepsy syndrome (FIRES): statements and supporting evidence. Epilepsia. 2022, 63:2840-64. 10.1111\/epi.17397","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S177803","article-title":"Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies","volume":"15","author":"Serino D","year":"2019","unstructured":"Serino D, Santarone ME, Caputo D, Fusco L. Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies. Neuropsychiatr Dis Treat. 2019, 15:1897-903. 10.2147\/NDT.S177803","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur K","year":"2019","unstructured":"Kothur K, Bandodkar S, Wienholt L, Chu S, Pope A, Gill D, Dale RC. Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus. Epilepsia. 2019, 60:1678-88. 10.1111\/epi.16275","journal-title":"Epilepsia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma H","year":"2015","unstructured":"Sakuma H, Tanuma N, Kuki I, Takahashi Y, Shiomi M, Hayashi M. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2015, 86:820-2. 10.1136\/jnnp-2014-309388","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: an international cohort","volume":"7","author":"Lai YC","year":"2020","unstructured":"Lai YC, Muscal E, Wells E, et al.. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. Ann Clin Transl Neurol. 2020, 7:2467-74. 10.1002\/acn3.51229","journal-title":"Ann Clin Transl Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun JS","year":"2018","unstructured":"Jun JS, Lee ST, Kim R, Chu K, Lee SK. Tocilizumab treatment for new onset refractory status epilepticus. Ann Neurol. 2018, 84:940-5. 10.1002\/ana.25374","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03250.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children","volume":"52","author":"Kramer U","year":"2011","unstructured":"Kramer U, Chi CS, Lin KL, et al.. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011, 52:1956-65. 10.1111\/j.1528-1167.2011.03250.x","journal-title":"Epilepsia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14684","article-title":"The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): a literature review","volume":"60","author":"Culleton S","year":"2019","unstructured":"Culleton S, Talenti G, Kaliakatsos M, Pujar S, D'Arco F. The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): a literature review. Epilepsia. 2019, 60:585-92. 10.1111\/epi.14684","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5334\/jbsr.3142","article-title":"The claustrum sign in febrile infection-related epilepsy syndrome (FIRES)","volume":"107","author":"Di Dier K","year":"2023","unstructured":"Di Dier K, Dekesel L, Dekeyzer S. The claustrum sign in febrile infection-related epilepsy syndrome (FIRES). J Belg Soc Radiol. 2023, 107:45. 10.5334\/jbsr.3142","journal-title":"J Belg Soc Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0883073816669450","article-title":"Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) In the acute and chronic phases","volume":"32","author":"Gofshteyn JS","year":"2017","unstructured":"Gofshteyn JS, Wilfong A, Devinsky O, et al.. Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) In the acute and chronic phases. J Child Neurol. 2017, 32:35-40. 10.1177\/0883073816669450","journal-title":"J Child Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1597271","article-title":"Febrile infection-related epilepsy syndrome: Clinical review and hypotheses of epileptogenesis","volume":"48","author":"van Baalen A","year":"2017","unstructured":"van Baalen A, Vezzani A, H\u00e4usler M, Kluger G. Febrile infection-related epilepsy syndrome: Clinical review and hypotheses of epileptogenesis. Neuropediatrics. 2017, 48:5-18. 10.1055\/s-0036-1597271","journal-title":"Neuropediatrics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492251-super-refractory-status-epilepticus-in-febrile-infection-related-epilepsy-syndrome-triggered-by-influenza-a-a-pediatric-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T13:18:08Z","timestamp":1783257488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492251-super-refractory-status-epilepticus-in-febrile-infection-related-epilepsy-syndrome-triggered-by-influenza-a-a-pediatric-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.112092","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,5]]}}}